2/29/2024 | CV | Market Commentary: NextEra Energy improves; Global Payments active; LivePerson crumbles; Shift4 volatile
|
2/29/2024 | CV | Market Commentary: Morning Commentary: NextEra Energy convertible notes improve; LivePerson crumbles
|
7/12/2023 | CV | Market Commentary: Ventas, American Water exchangeables hit new heights; LivePerson outperforms; Airbnb up
|
3/28/2023 | CV | Market Commentary: Expedia convertibles draw buyers; Radius active; SmileDirectClub lower on stalled talks
|
3/23/2023 | CVLM | LivePerson buys back $157.5 million of 0.75% convertibles due 2024
|
3/16/2023 | CV | Market Commentary: Freshpet convertible notes skyrocket on debut; Esperion, LivePerson tank on hedge
|
3/1/2022 | CV | Market Commentary: LivePerson convertible notes rebound; Lucid contracts post-earnings; MicroStrategy up
|
3/1/2022 | CV | Market Commentary: Morning Commentary: LivePerson convertible notes rebound in early secondary trading
|
2/25/2022 | CV | Market Commentary: Secondary tone improves; Peabody jumps on debut; LivePerson, Opendoor down; Etsy gains
|
7/13/2021 | CV | Market Commentary: Two Harbors in focus, expands; Southwest, LivePerson active; SmileDirectClub down outright
|
12/7/2020 | CV | LivePerson greenshoe ups six-year convertibles to $517.5 million
|
12/2/2020 | CV | Market Commentary: Shift4 tightens talk; Progenity on deck; LivePerson expands on debut; Slack contracts
|
12/2/2020 | CV | Market Commentary: Morning Commentary: Progenity, Shift4 convertibles on deck; LivePerson expands on debut
|
12/2/2020 | CV | New Issue: LivePerson prices $450 million six-year convertible notes to yield 0%, up 42.5%
|
12/1/2020 | CV | Market Commentary: Shift4 Payments, LivePerson, Progenity convertible offerings eyed; NextEra contracts
|
12/1/2020 | CV | Market Commentary: Morning Commentary: Shift4 Payments, LivePerson on tap; NextEra active, trades down
|
12/1/2020 | CV | LivePerson talks $450 million six-year convertible notes to yield 0%-0.5%, up 35%-40%
|
11/8/2019 | CV | Market Commentary: Stanley Black & Decker ‘trades well’; Cytokinetics drags outright; LivePerson adds on swap
|
11/8/2019 | CV | Market Commentary: Morning Commentary: Stanley Black & Decker mandatory ‘trades well’; Cytokinetics drags
|
2/28/2019 | CV | Market Commentary: LivePerson oversubscribed, expands on debut; Applied Optoelectronics eyed; Novavax tanks
|
2/28/2019 | CV | Market Commentary: Morning Commentary: LivePerson hits primary market; Applied Optoelectronics eyed
|
2/28/2019 | CV | New Issue: LivePerson prices upsized $200 million five-year convertibles to yield 0.75%, up 35%
|
2/27/2019 | CV | Market Commentary: Applied Optoelectronics convertibles on tap; LivePerson eyed; Danaher issue in demand
|
2/27/2019 | CV | Market Commentary: Morning Commentary: Danaher, Prospect Capital tap convertibles market; LivePerson eyed
|
2/26/2019 | CV | Market Commentary: LivePerson on tap; Danaher’s mandatory convertible preferreds eyed; Nio gains outright
|
2/26/2019 | CV | LivePerson talks $150 million five-year convertible notes to yield 0.625%-1.125%, up 30%-35%
|